Back to search results

Efficacy of Tezepelumab in Peanut Oral Immunotherapy

Abroad (travel likely)RecruitingPHASE2

Conditions

Peanut Allergy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Arkansas Children's Hospital Research Institute: Department of Pediatrics, Allergy & Immunology, Little Rock, Arkansas, United States

    Contact: Study coordinator (Erin Thomas) · ThomasES@archildrens.org · 501-364-2325
    Contact: Principal Investigator (Stacie Jones, MD)

  • University of California, Los Angeles: Department of Medicine, Division of Clinical Immunology and Allergy, Los Angeles, California, United States

    Contact: Study coordinator (Stacey Zedeck) · sskura@mednet.ucla.edu · 310-825-6482
    Contact: Principal Investigator (Maria Garcia-Lloret, MD)

  • Johns Hopkins Children's Center: Department of Allergy & Immunology, Baltimore, Maryland, United States

    Contact: Study coordinator (Paul Jones) · pjones48@jh.edu · 410-502-1711
    Contact: Principal Investigator (Bob Wood, MD)

  • Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit, Boston, Massachusetts, United States

    Contact: Study coordinator (Andrew Kim) · akim90@mgh.harvard.edu · 617-643-8683
    Contact: Principal Investigator (Sarita Patil, MD)

  • Boston Children's Hospital: Allergy and Asthma Program, Boston, Massachusetts, United States

    Contact: Study coordinator (Isabella Viola) · Isabella.Viola@childrens.harvard.edu · 617-355-1734
    Contact: Principal Investigator (Rima Rachid, MD)

  • The University of Michigan: Division of Allergy and Clinical Immunology, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Lea Franco) · lmfranco@med.umich.edu · 734-647-7999
    Contact: Principal Investigator (Ian Slack, MD)

  • Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, New York, New York, United States

    Contact: Study coordinator (Xueru Mu) · xueru.mu@mssm.edu · 347-335-7148
    Contact: Principal Investigator (Scott Sicherer, MD)

  • North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Lauren Herlihy) · lekoch@email.unc.edu · 919-962-4406
    Contact: Principal Investigator (Edwin Kim, MD)

  • Cincinnati Children's Hospital Medical Center: Division of Allergy and Immunology, Cincinnati, Ohio, United States

    Contact: Study coordinator (Jennifer Jennings) · jennifer.jennings2@cchmc.org · 513-636-7085
    Contact: Principal Investigator (Amal Assa'ad, MD)

  • University of Texas Southwestern Medical Center: Division of Allergy and Immunology, Dallas, Texas, United States

Study leads

  • Edwin H Kim, M.D., M.S.

    Study Chair

    North Carolina Children's Hospital: Department of Pediatrics, Division of Allergy, Immunology and Rheumatology

  • Sarita Patil, M.D.

    Study Chair

    Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit

View source on ClinicalTrials.gov(opens in a new tab)